Hecla Reports Third Quarter 2023 Results
For The Period Ended: September 30, 2023COEUR D'ALENE, Idaho--(BUSINESS WIRE)--Hecla Mining Company (NYSE:HL) today announced third quarter 2023 operating and...
Day: November 6, 2023
Brad Burton PharmD, Highlights Traineeship Program for Practicing Pharmacy Professionals
CHAPEL HILL, NC / ACCESSWIRE / November 6, 2023 / Renowned clinical pharmacy specialist, Dr. Brad Burton is extending his...
908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System
Automation combined with on-line monitoring during the cell expansion step can bring cell therapy manufacturing efficiencies and enable increased patient...
FSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus
TORONTO, ON / ACCESSWIRE / November 6, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
NeoGenomics Reports Third Quarter 2023 Results
Third Quarter Revenue Increased 18% to $152 MillionFORT MYERS, FL / ACCESSWIRE / November 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO)...
Novo Integrated Sciences Announces Reverse Stock Split
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that the Company will undertake...
Netsmart Showcases Advancements Driving Value-Based Care Success for Senior Living Providers at LeadingAge 2023
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#HealthcareIT--Netsmart, an award-winning healthcare solutions and software provider, will showcase advanced technology of the CareFabric® platform to...
Curated’s Latest Empowering Initiative: Complimentary Discovery Calls Supporting Individuals on Their Psychedelic Healing Journey
NEW YORK, NY / ACCESSWIRE / November 6, 2023 / Curated Mental Health is thrilled to announce an empowering initiative...
Keona Health Announces the Successful Go-Live of North Florida Women’s Center
TALLAHASSEE, FL / ACCESSWIRE / November 6, 2023 / Keona Health, a leading provider of patient-access systems, is thrilled to...
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
GLENOLDEN, PA / ACCESSWIRE / November 6, 2023 / The Charcot-Marie-Tooth Association announced Nov. 6 that Suzanne (Sue) Bruhn, PhD,...
SENATE MOVES TO END RAPE KIT BACKLOG: Votes to Renew Debbie Smith Act-Most Effective Anti-Rape Legislation
Washington, D.C.--(Newsfile Corp. - November 6, 2023) - The U.S. Senate voted to renew the Debbie Smith Act, a law...
KelaHealth Surgical Intelligence Platform Helps Surgeons Avoid Serious Complications
Real-time deployment of AI tool in Duke Colorectal Surgery workflows leads to a reduction in AKI and readmissions in new...
Edifecs to Speak on the Power of Artificial Intelligence at 2023 WEDI National Conference
Learn how AI unlocks a new level of value-based care and clinical decisions supportBELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global health...
Britannia Provides Update on Mining Division Including Britannia Mining Solutions and Paragon Geochemical
Britannia Mining Solutions is a partially owned subsidiary of Britannia Life SciencesBritannia Mining Solutions owns Paragon Geochemical, a full-service, state-of-the-art...
BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
POMPANO BEACH, FL / ACCESSWIRE / November 6, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company...
Ainos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONA
Ainos and SIDSCO will cooperate to accelerate the development of new animal drugs based on Ainos' VELDONA® low-dose oral interferonUpcoming...
Gemina Labs Ltd Appoints Stifel as Financial Advisor
VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7), a diagnostics technology company, is pleased to...
SELLAS Life Sciences Presents Positive Key Immunobiological and Clinical Data from Phase 1/2 Trial of Galinpepimut-S (GPS) in Combination with Keytruda® in WT1+ Platinum-Resistant Advanced Ovarian Cancer at the International Gynecologic Cancer Society 2023 Annual Global Meeting
Median overall survival for GPS and Keytruda® combination was 18.4 Months compared to 13.8 Months in a Keytruda® single agent...
Desjardins Group donates $500K to the MUHC Foundation to support career training for students of the health sciences
The gift supports the Desjardins Centre for Advanced Training at the Research Institute of the McGill University Health Centre, which...
Nexcella Presents NXC-201 Data at 65th American Society of Hematology (ASH) Annual Meeting in 63 Relapsed/Refractory Multiple Myeloma Patients
95% overall response rate observed in relapsed/refractory multiple myeloma patients not previously treated with BCMA-targeted therapy98% overall response rate observed...